Analysis of efficacy and toxicity of thalidomide in 122 patients with multiple myeloma: response of soft-tissue plasmacytomas

被引：12

作者：

Wu, KL

Helgason, HH

van der Holt, B

Wijermans, PW

Lokhorst, HM

Smit, WM

Sonneveld, P

机构：

[1] Univ Hosp Rotterdam Dijkzigt, Erasmus MC, Dept Hematol, NL-3000 CA Rotterdam, Netherlands

[2] Med Spectrum Twente, Dept Internal Med, Enschede, Netherlands

[3] Erasmus MC, HOVON Data Ctr, Rotterdam, Netherlands

[4] Leyenburg Hosp, Dept Hematol, Rotterdam, Netherlands

[5] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands

来源：

LEUKEMIA | 2005年 / 19卷 / 01期

关键词：

D O I：

10.1038/sj.leu.2403568

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：143 / 145

页数：4

共 8 条

[1] Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation [J].

Biagi, JJ ;

Mileshkin, L ;

Grigg, AP ;

Westerman, DW ;

Prince, HM .

BONE MARROW TRANSPLANTATION, 2001, 28 (12) :1145-1150

[2] Thalidomide in multiple myeloma:: lack of response of soft-tissue plasmacytomas [J].

Bladé, J ;

Perales, M ;

Rosiñol, L ;

Tuset, M ;

Montoto, S ;

Esteve, O ;

Cobo, F ;

Villela, L ;

Rafel, M ;

Nomdedeu, B ;

Montserrat, E .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (02) :422-424

[3] Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma [J].

Kumar, S ;

Gertz, MA ;

Dispenzieri, A ;

Lacy, MQ ;

Geyer, SM ;

Iturria, NL ;

Fonseca, R ;

Hayman, SR ;

Lust, JA ;

Kyle, RA ;

Greipp, PR ;

Witzig, TE ;

Rajkumar, SV .

MAYO CLINIC PROCEEDINGS, 2003, 78 (01) :34-39

[4] Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma [J].

Ribas, C ;

Colleoni, G ;

Almeida, M ;

Duch, CR ;

Ohashi, C ;

Segreto, R ;

Silva, MR .

ACTA ONCOLOGICA, 2004, 43 (02) :215-216

[5]

Rosinol L, 2004, HAEMATOLOGICA, V89, P832

[6] An UK myeloma forum phase II study of thalidomide; long term follow-up and recommendations for treatment [J].

Schey, SA ;

Cavenagh, J ;

Johnson, R ;

Child, JA ;

Oakervee, H ;

Jones, RW .

LEUKEMIA RESEARCH, 2003, 27 (10) :909-914

[7] Antitumor activity of thalidomide in refractory multiple myeloma. [J].

Singhal, S ;

Mehta, J ;

Desikan, R ;

Ayers, D ;

Roberson, P ;

Eddlemon, P ;

Munshi, N ;

Anaissie, E ;

Wilson, C ;

Dhodapkar, M ;

Zeldis, J ;

Barlogie, B ;

Siegel, D ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571

[8] Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy [J].

Zangari, M ;

Anaissie, E ;

Barlogie, B ;

Badros, A ;

Desikan, R ;

Gopal, AV ;

Morris, C ;

Toor, A ;

Siegel, E ;

Fink, L ;

Tricot, G .

BLOOD, 2001, 98 (05) :1614-1615

← 1 →